In a major private equity buy out deal, life science giant Thermo Fisher Scientific will pay up to $9.4bn cash to acquire drug trial data software firm Clario.
Read more: Thermo Fisher acquires drug trial software firm Clario for up to $9.4bn
October 30, 2025 - BY Silicon Republic